Milestone Pharmaceuticals Inc.
For the period ended Jun 10, 2025. Filed Apr 30, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 10, 2025 · Filed Apr 30, 2025
Contents
Engagement Program
The Company maintains a robust shareholder engagement program that is designed to have several touchpoints throughout the year in order to create multiple opportunities to solicit feedback on topics of importance to shareholders:
| Season | Engagement Focus |
|---|---|
| Spring/Summer | The Company releases its proxy statement with respect to its upcoming annual meeting and extends invitations to institutional investors to discuss their perspectives, including the matters to be voted on at the upcoming annual meeting. |
| Fall | Our Board considers the results of the annual meeting and shareholder feedback more broadly, which helps identify the key topics on which to engage shareholders through the end of the year. |
| Winter | Our Board and management engage with shareholders with respect to a number of topics, including our corporate governance practices. |
The Company frequently updates its shareholders and analysts on key developments in drug research and development (“R&D”), commercialization strategy, approvals and other milestones through webcasts.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.